The utility of futility

Rory L Smoot^{1

2}, David M Nagorney¹

Affiliations

¹ Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.

Comment

Rory L Smoot et al. Hepatology. 2024.

. 2024 Feb 1;79(2):264-266.

doi: 10.1097/HEP.0000000000000614. Epub 2023 Sep 28.

Rory L Smoot^{1

2}, David M Nagorney¹

¹ Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.

No abstract available

Comment on

Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation.
Ratti F, Marino R, Olthof PB, Pratschke J, Erdmann JI, Neumann UP, Prasad R, Jarnagin WR, Schnitzbauer AA, Cescon M, Guglielmi A, Lang H, Nadalin S, Topal B, Maithel SK, Hoogwater FJH, Alikhanov R, Troisi R, Sparrelid E, Roberts KJ, Malagò M, Hagendoorn J, Malik HZ, Olde Damink SWM, Kazemier G, Schadde E, Charco R, de Reuver PR, Groot Koerkamp B, Aldrighetti L; Perihilar Cholangiocarcinoma Collaboration Group. Ratti F, et al. Hepatology. 2024 Feb 1;79(2):341-354. doi: 10.1097/HEP.0000000000000554. Epub 2023 Aug 3. Hepatology. 2024. PMID: 37530544

1. Mueller M, Breuer E, Mizuno T, Bartsch F, Ratti F, Benzing C, et al. Perihilar cholangiocarcinoma—novel benchmark values for surgical and oncological outcomes from 24 expert centers. Ann Surg. 2021;274:780–8.
1. Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G, et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: Results of an Italian multicenter analysis of 440 patients. Arch Surg. 2012;147:26–34.
1. Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7:65.
1. Gray S, Lamarca A, Edeline J, Klumpen HJ, Hubner RA, McNamara MG, et al. Targeted therapies for perihilar cholangiocarcinoma. Cancers (Basel). 2022;14:1789.
1. Wang N, Huang A, Kuang B, Xiao Y, Xiao Y, Ma H. Progress in radiotherapy for cholangiocarcinoma. Front Oncol. 2022;12:868034.